DrugDashboards

Sheffield Triple Antibiotic

Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate · BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g · Ointment · Topical · Sheffield Pharmaceuticals LLC

NDC 11527-0162-55 · 1 TUBE in 1 CARTON / 28 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $0.0886 per gram over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Oct 2022Sep 2026$0.0886
48 price points · per GMSource: CMS NADAC

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for bacitracin zinc, neomycin sulfate, polymyxin b sulfate (other) in the next 90 days

sole-source market · price up 3% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M004
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedNov 22, 2013
    Faria Limited LLC dba Sheffield PharmaceuticalsMicrobial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing

Manufacturers of Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate (Ointment)

LabelerStrengthFirst seenLast seen
Sheffield Pharmaceuticals LLCBACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/gAug 26, 2026Sep 2, 2026
Water-Jel TechnologiesBACITRACIN ZINC 417.8 [iU]/g; POLYMYXIN B SULFATE 5322.8 [iU]/g; NEOMYCIN SULFATE 3.5 mg/gAug 26, 2026Sep 2, 2026
Sheffield Pharmaceuticals LLCBACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 3.5 mg/g; NEOMYCIN SULFATE 5000 [USP'U]/gJul 22, 2026Aug 19, 2026
Water-Jel TechnologiesBACITRACIN ZINC 417.8 [iU]/g; POLYMYXIN B SULFATE 3.5 mg/g; NEOMYCIN SULFATE 5322.8 [iU]/gJul 22, 2026Aug 19, 2026
Sheffield Pharmaceuticals LLCBACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/gJul 15, 2026Jul 15, 2026
Water-Jel TechnologiesBACITRACIN ZINC 417.8 [iU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5322.8 [iU]/gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sheffield Triple Antibiotic — NDC 11527-0162-55," retrieved September 3, 2026, https://drugdashboards.com/drug/11527016255.

Free to cite with attribution — see how the data is put together.